MaxCyte Announces Change in Major Shareholder Voting Rights
PremiumCompany AnnouncementsMaxCyte Announces Change in Major Shareholder Voting Rights
10d ago
BlackRock Increases Stake in MaxCyte to 7.87%
Premium
Company Announcements
BlackRock Increases Stake in MaxCyte to 7.87%
10d ago
MaxCyte Awards Stock Options and Units to Executives
Premium
Company Announcements
MaxCyte Awards Stock Options and Units to Executives
11d ago
MaxCyte price target lowered to $6 from $8 at BTIG
PremiumThe FlyMaxCyte price target lowered to $6 from $8 at BTIG
23d ago
MaxCyte price target lowered to $9 from $11 at Stifel
Premium
The Fly
MaxCyte price target lowered to $9 from $11 at Stifel
23d ago
MaxCyte’s Strategic Growth and Strong Positioning Justify Buy Rating Despite Revenue Decline
Premium
Ratings
MaxCyte’s Strategic Growth and Strong Positioning Justify Buy Rating Despite Revenue Decline
23d ago
Is MXCT a Buy, Before Earnings?
PremiumPre-EarningsIs MXCT a Buy, Before Earnings?
27d ago
MaxCyte Expands Stock Capital with New Issuance
Premium
Company Announcements
MaxCyte Expands Stock Capital with New Issuance
1M ago
MaxCyte Experiences Shift in Major Holdings by BlackRock
Premium
Company Announcements
MaxCyte Experiences Shift in Major Holdings by BlackRock
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100